"Vinblastine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antitumor alkaloid isolated from Vinca rosea. (Merck, 11th ed.)
| Descriptor ID |
D014747
|
| MeSH Number(s) |
D03.132.436.681.827.650 D03.633.100.473.402.681.827.650
|
| Concept/Terms |
Velban- Velban
- Vinblastina Lilly
- Velbe
|
Below are MeSH descriptors whose meaning is more general than "Vinblastine".
Below are MeSH descriptors whose meaning is more specific than "Vinblastine".
This graph shows the total number of publications written about "Vinblastine" by people in this website by year, and whether "Vinblastine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vinblastine" by people in Profiles.
-
Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience. Clin Lymphoma Myeloma Leuk. 2022 07; 22(7):e435-e442.
-
Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma. Blood. 2021 03 11; 137(10):1318-1326.
-
A Timely Oral Option: Single-Agent Vinorelbine in Desmoid Tumors. Oncologist. 2020 12; 25(12):e2013-e2016.
-
Drug repositioning in sarcomas and other rare tumors. EBioMedicine. 2016 Apr; 6:4-5.
-
Pruritus and hyperpigmented streaks. The diagnosis: flagellate hyperpigmentation. Cutis. 2014 May; 93(5):E9-10.
-
Advanced aggressive fibromatosis: Effective palliation with chemotherapy. Acta Oncol. 2011 Apr; 50(3):455-61.
-
Single-agent versus combination chemotherapy in patients with advanced non-small cell lung cancer and a performance status of 2: prognostic factors and treatment selection based on two large randomized clinical trials. J Thorac Oncol. 2009 Jul; 4(7):869-74.
-
A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer. Lung Cancer. 2004 Aug; 45(2):243-53.
-
Phase I trial of concomitant vinorelbine, cisplatin, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies. Gynecol Oncol. 2004 Mar; 92(3):801-5.
-
Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial. Lung Cancer. 2001 Dec; 34 Suppl 4:S65-9.